Skip to main content
Log in

Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi

  • Review
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Scientists are making efforts to search for new metabolites as they are essential lead molecules for the drug discovery, much required due to the evolution of multi drug resistance and new diseases. Moreover, higher production of known drugs is required because of the ever growing population. Microorganisms offer a vast collection of chemically distinct compounds that exhibit various biological functions. They play a crucial role in safeguarding crops, agriculture, and combating several infectious ailments and cancer. Research on fungi have grabbed a lot of attention after the discovery of penicillin, most of the compounds produced by fungi under normal cultivation conditions are discovered and now rarely new compounds are discovered. Treatment of fungi with the epigenetic modifiers has been becoming very popular since the last few years to boost the discovery of new molecules and enhance the production of already known molecules. Epigenetic literally means above genetics that actually does not alter the genome but alter its expression by altering the state of chromatin from heterochromatin to euchromatin. Chromatin in heterochromatin state usually doesn’t express because it is closely packed by histones in this state. Epigenetic modifiers loosen the packing of chromatin by inhibiting DNA methylation and histone deacetylation and thus permit the expression of genes that usually remain dormant. This study delves into the possibility of utilizing epigenetic modifying agents to generate pharmacologically significant secondary metabolites from fungi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Acknowledgements

The authors are thankful to the Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR), New Delhi for the financial assistance.

Funding

This work was supported by the CSIR-Indian Institute of Integrative Medicine (MLP 21002).

Author information

Authors and Affiliations

Authors

Contributions

VS: Writing original draft, Formal analysis. SP: Draft manuscript preparation, Editing and Review. NS: Conceived and designed the analysis. VA: Drafted the article and revised. UG: Formal analysis and review. SJ: Conceptualization, Formal analysis, Final review, Editing and supervision.

Corresponding author

Correspondence to Sundeep Jaglan.

Ethics declarations

Competing interest

The authors declare that they have no conflict of interests.

Ethical approval

There is no study in this article that involves the participation of humans or animals.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, V., Panjgotra, S., Sharma, N. et al. Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi. Biotechnol Lett 46, 297–314 (2024). https://doi.org/10.1007/s10529-024-03478-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-024-03478-z

Keywords

Navigation